ARCT Q1 2023 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$217M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$80M+1431.0% YoY

Gross Profit

$29M35.5% margin

Operating Income

$15M18.4% margin

Net Income

$51M63.2% margin

EPS (Diluted)

$1.87

QoQ Revenue Growth

-49.9%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$37M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$471M

Total Liabilities

$142M

Stockholders' Equity

$329M

Cash & Equivalents

$328M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80M	$5M	+1431.0%
Gross Profit	$29M	-$40M	+171.9%
Operating Income	$15M	-$50M	+129.3%
Net Income	$51M	-$51M	+199.2%

Revenue Segments

Collaboration Revenue

$80M99%

Grant

$556,0001%